# Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping

> **NIH NIH R44** · EPICYPHER, INC. · 2022 · $103,580

## Abstract

Candidate Eligibility Statement
 The goal of this diversity supplement application is to provide career development support for Dr. Allison
Hickman, a bioinformatician who aspires to (and with support could perform) leadership roles in commercial
science. Women have been under-represented in science leadership, particularly in the field of bioinformatics,
and this award would formally address the issue by supporting a truly talented individual. Dr. Hickman is a US
citizen and full-time employee at EpiCypher Inc., a Small Business Concern (SBC) eligible to submit applications
to the National Institutes of Health. EpiCypher was recently awarded an SBIR Fast-Track Grant from NHGRI
[R44 HG011875] that is currently in year one (of three) and is eligible for diversity supplement support.
5.12.2022
Dr. Allison Hickman - Diversity Supplement Candidate (Research Scientist) Date
5.11.2022
Dr. Martis Cowles - EpiCypher Signing Official (Chief Business Officer) Date

## Key facts

- **NIH application ID:** 10622310
- **Project number:** 3R44HG011875-01A1S1
- **Recipient organization:** EPICYPHER, INC.
- **Principal Investigator:** Michael-Christopher Keogh
- **Activity code:** R44 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $103,580
- **Award type:** 3
- **Project period:** 2022-02-01 → 2023-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10622310

## Citation

> US National Institutes of Health, RePORTER application 10622310, Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping (3R44HG011875-01A1S1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10622310. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*